Celara Diagnostics, known for its advanced radiology and pathology services, complements Redcliffe's extensive network of over 80 labs and 2,000+ collection centres across India. Celara’s specialization in areas such as neurology, cardiology, and pulmonology bring valuable synergies for Redcliffe as it enters new regions. This acquisition will also support Redcliffe's plans to expand its lab network, collection centres and home collection services reinforcing its Pan-India growth strategy.

This move highlights Redcliffe Labs’ commitment to scaling its operations through partnerships and strategic investments.

This marks Wodehouse Capital’s third transaction in the single specialty segment over the past 12 months, where we have acted as advisors, further strengthening our position within the healthcare vertical and solidifying our leadership in the diagnostics sector.